A bad vial often looks fine.
You can tell a peptide has gone bad when the mixed solution turns cloudy, shows specks or strands, changes colour, or stays foamy after resting; when the powder looks wet, sticky, shrunken or discoloured; or when the vial is past its expiry, past its in-use window, was frozen against its label, or has a broken seal. Any one of those means discard it. The catch is that a peptide can also lose much of its strength with none of those signs, which is why the date, the storage history and a batch test report matter as much as your eyes.
If you have ever held a vial up to the light and wondered, you are asking the right question. FDA labels for peptide drugs tell patients to do exactly that check before every dose.
🔑 Key Takeaways
- Cloudiness, particles and colour change are discard signs on every peptide label we checked.
- Some colours are normal. Copper makes GHK-Cu blue, and Zepbound can be slightly yellow.
- The invisible failure is the common one: chemical breakdown you cannot see.
- Mixed peptides run on a clock, and gray-market vials never print it.
- Weaker results are a clue, not proof. A test report is proof.
Below: why peptides break down, the signs in powder and in liquid, a quick table for the vial in your hand, the timeline problem, and what to do if you already injected one that seemed off. For the storage side of the story, see how to store peptides.
Why Peptides Degrade
Peptides are fragile chains.
Drug-stability scientists split the damage into two kinds. Chemical instability changes the molecule itself; physical instability makes intact molecules clump together (Manning et al., 2010). A review of impurities in peptide medicines lists the usual chemical routes: oxidation of amino acid side chains, plus degradation reactions such as β-elimination, diketopiperazine, pyroglutamate and succinimide formation (D'Hondt et al., 2014).
Clumping, called aggregation, is the physical side. A 2017 review names what drives it: sequence, concentration, pH, excipients, chemical damage, surfaces, impurities, temperature, agitation and the freeze-drying process itself (Zapadka et al., 2017). In plain terms: heat, shaking, the wrong water, and time.
Here is why that matters for you. Oxidation or a broken bond rarely changes how a solution looks. Aggregation sometimes does, as haze or particles. So the signs you can see catch only part of what can go wrong.
Signs Your Peptide Powder Has Gone Bad
Good powder is dry and boring.
Freeze-dried peptides normally sit as a white to off-white cake or loose powder; the tesamorelin label, for example, describes a white to off-white powder (EGRIFTA WR label). Warning signs:
- Wet, sticky or syrupy powder. Moisture got in. Peptides are freeze-dried precisely because they keep better dry.
- A shrunken, melted-looking cake stuck to the glass, often from heat.
- Yellow or brown discolouration on a peptide that should be white.
- A cracked vial, loose crimp or punctured stopper before you ever used it.
- Powder that will not dissolve with gentle swirling, or leaves flakes behind.
A cake that has simply broken into pieces in transit is usually fine. Broken is not the same as melted.
Signs a Mixed Peptide Has Gone Bad
Labels set a simple bar.
The tesamorelin label says the mixed solution should be clear and colourless, and not to use it if solid particles appear or it is cloudy or coloured. It also says to let foam settle for a few seconds, then discard the vial if the solution still looks cloudy, discoloured or has particles (EGRIFTA WR label). The bacteriostatic water label tells users to inspect reconstituted drugs for clarity and freedom from unexpected precipitation or discolouration (bacteriostatic water label).
The word "unexpected" matters. Some peptides have a normal colour:
- Zepbound is labelled clear and colourless to slightly yellow (Zepbound label).
- GHK-Cu is blue because of its copper. Our GHK-Cu injection guide covers what it should look like.
What counts is change. A vial that was clear on mixing day and is hazy two weeks later has told you something.
How to Tell If Peptides Have Gone Bad: Signs at a Glance
Hold the vial to the light and check each row.
The Timeline Problem: Mixed Peptides Have a Clock
Mixing starts a countdown.
Approved peptide drugs print it. Reconstituted tesamorelin is discarded 7 days after mixing (EGRIFTA WR label). An opened multi-dose Zepbound vial is thrown away after 30 days or 4 weekly doses, even with liquid left (Zepbound label). Opened multi-dose vials in general are dated and discarded within 28 days unless the manufacturer says otherwise, the USP 797 rule cited by the CDC (CDC).
Gray-market peptides print none of this. Nobody has tested how long that vial stays good once mixed, and the bacteriostatic water label itself says not to store reconstituted solutions unless the drug's maker directs it (bacteriostatic water label). The practical answer: write the mix date on every vial, mix the smallest volume that covers a few weeks, and do not stretch a vial to save money. Our bacteriostatic water guide explains the 28-day trap in more detail.
Storage Mistakes That Ruin Peptides
Most bad vials were made bad.
- Heat and light. The Zepbound label says protect from heat and light and keep it in the carton (Zepbound label). A vial left in a hot car is suspect.
- Freezing a product that says do not freeze. Both the Zepbound and EGRIFTA WR labels say it, and Zepbound adds do not use if frozen.
- Shaking. Agitation is one of the named drivers of aggregation (Zapadka et al., 2017). Swirl instead.
- Leaving a needle in the stopper for repeated draws. The CDC warns this lets microbes into the fluid (CDC).
- Using sterile water for a multi-dose vial. Without a preservative, contamination risk climbs with every puncture. See bacteriostatic vs sterile water vs saline.
- Long trips without a plan. How to travel with peptides covers cooling and packing.
What Weaker Results Can and Cannot Tell You
Results fade for many reasons.
If a peptide that worked for you seems to stop working while the dose, mixing and schedule stayed the same, degradation is one suspect. So are a dose-math slip after a change in water volume, a different batch, a site with lumps from poor rotation, and normal tolerance. Before blaming the vial, recheck your units with the peptide calculator and your injection rotation in how to inject peptides.
How to Confirm: Test Reports and Third-Party Testing
Only a lab can be sure.
Purity testing by HPLC and identity testing by mass spectrometry are how manufacturers check for the impurities and degradation products described above (D'Hondt et al., 2014). For you, that means two things. Before buying, check that the seller posts a recent test report for the exact batch; our guide to reading a peptide COA shows what a real one contains, and how to verify a Janoshik report shows how to check one is genuine. After buying, an independent lab can test a vial you are unsure about.
A test report only describes the vial on the day it was tested, so storage after that is on you. If you are comparing sellers, our list of the best peptide vendors compares them side by side.
What to Do If You Already Injected a Bad Peptide
Most of the time, nothing happens.
A degraded peptide is usually just weaker. The bigger worry is contamination. Watch the injection site for the next few days. Spreading redness, heat, swelling, pus or a fever are infection signs and need a doctor. Hives, swelling of the lips or face, or trouble breathing need emergency care. Keep the vial and its label so your doctor knows what you used, and stop using that vial. Our peptide side effects guide covers normal site reactions versus warning signs.
Starting out? The beginner's guide to using peptides puts mixing, dosing, injection and storage in order.
Frequently Asked Questions
Sources
- EGRIFTA WR (tesamorelin) Prescribing Information and Instructions for Use, Theratechnologies, revised 03/2025 (DailyMed)
- Zepbound (tirzepatide) U.S. Prescribing Information, Eli Lilly, revised 08/2026
- Bacteriostatic Water for Injection, USP label (Henry Schein), DailyMed
- CDC. Injection Safety: Clinical Safety and Safe Injection Practices (incl. USP 797 28-day multi-dose vial rule)
- Manning MC, et al. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-75. PMID 20143256
- Zapadka KL, et al. Factors affecting the physical stability (aggregation) of peptide therapeutics. Interface Focus. 2017;7(6):20170030. PMID 29147559
- D'Hondt M, et al. Related impurities in peptide medicines. J Pharm Biomed Anal. 2014;101:2-30. PMID 25044089
This article is for informational and educational purposes only and is not medical advice. If you have injected a product that looked wrong and feel unwell, contact a licensed clinician. Peptides sold without a prescription have no FDA approval, and their storage and use should be discussed with your doctor.
